NREP
NEW REPRESENTATIVE AT IB RECEIVED
01/08/2026
Back to search
Official data from USPTO
BIOINTESTIL
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
29
Latest update
01/09/2026
Trademark type
Combined
Nice classes
5
Filing date
11/12/2021
Registration date
03/26/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/26/2024
Last transaction
01/09/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
5
Owner type
99
Owner location
IT
Examiner
DONEGAN,DANIEL P
Law office
L40
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the stylized wording "BIOINTESTIL" with the verbal part "BIO" in capital letters and the verbal part "INTESTIL" in lower case.
Holders and representatives
Holders
Targeting Gut Disease S.r.l.
Representatives
Alexander Lazouski LAZOUSKI IP LLC
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Probiotic dietary supplements; dietaryvitaminnutritional and mineral supplements and dietetic food supplements; pharmaceuticalsanti-infectivesantimicrobialantioxidant and anti-inflammatory; dietetic food and beverages adapted for medical use; infant formula; food supplements for humans
Publications
History of USPTO decisions and trademark events.
29 publications found
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
11/17/2024
FICS
FINAL DISPOSITION NOTICE SENT TO IB
10/07/2024
FIMP
FINAL DISPOSITION PROCESSED
10/07/2024
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
06/27/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
03/26/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
03/26/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/09/2024
PUBO
PUBLISHED FOR OPPOSITION
01/09/2024
GPNX
NOTIFICATION PROCESSED BY IB
01/07/2024
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
12/20/2023
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
12/20/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/20/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/05/2023
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
09/16/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
08/30/2023
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
08/30/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/11/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/10/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/10/2023
RFNT
REFUSAL PROCESSED BY IB
11/08/2022
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
10/15/2022
RFRR
REFUSAL PROCESSED BY MPU
10/15/2022
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
08/26/2022
CNRT
NON-FINAL ACTION WRITTEN
08/25/2022
DOCK
ASSIGNED TO EXAMINER
08/24/2022
MAFR
APPLICATION FILING RECEIPT MAILED
03/29/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/25/2022
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
03/24/2022
Continuous trademark protection
Get notified about every new filing that threatens BIOINTESTIL or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.